2.0
26. Juli 2012
Mitarbeiter (anonym)
Aktueller Mitarbeiter, mehr als 5 Jahre
Wilmington, DE
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Generous compensation and benefits, nice facilities, business-casual attire.
Kontras
Successive rounds of layoffs offset only by new positions in China; recent product failures and weak pipeline including at MedImmune biotech arm; current near-ban on travel, relocations, hiring from the outside and use of outside consultants; timid, risk-averse management; in-bred, protect-each-other culture at the C-suite level.